About the Company
We do not have any company description for Xencor Inc at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $XNCR News
Analyst Scoreboard: 6 Ratings For Xencor
In the preceding three months, 6 analysts have released ratings for Xencor (NASDAQ:XNCR), presenting a wide array of ...
Xencor Inc XNCR
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Xencor Appoints Bart Cornelissen as Chief Financial Officer
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, today announced the appointment of Bart ...
Xencor Appoints Bart Cornelissen As CFO
(RTTNews) - Xencor, Inc. (XNCR), focused on cancer and other serious diseases, on Tuesday announced that it has appointed Bart Cornelissen as chief financial officer. On October 26, 2023 ...
Xencor: Q4 Earnings Snapshot
PASADENA, Calif. (AP) — PASADENA, Calif. (AP) — Xencor Inc. (XNCR) on Tuesday reported a loss of $19.1 million in its fourth quarter. The Pasadena, California-based company said it had a loss ...
Xencor, Inc. Common Stock (XNCR)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past ...
Xencor Appoints Bart Cornelissen as Chief Financial Officer
PASADENA, Calif., April 09, 2024--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other ...
Xencor Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Loading the latest forecasts...